Early myoclonic encephalopathy in 9q33-q34 deletion encompassing STXBP1 and SPTAN1

Francesco Nicita, Fiorenza Ulgiati, Laura Bernardini, Giacomo Garone, Laura Papetti, Antonio Novelli, Alberto Spalice

Research output: Contribution to journalArticlepeer-review


Deletions in the 9q33-q34 region have been reported in patients with early onset epileptic encephalopathy, but a consistent phenotype has yet to emerge. We report on the diagnosis of a de novo 9q33-q34.12 microdeletion of 4 Mb in a 15-month-old girl presenting with severe psychomotor delay, facial dysmorphisms, thin corpus callosum and early myoclonic encephalopathy. This deletion encompasses 101 RefSeq genes, including the four autosomal dominant genes STXBP1, SPTAN1, ENG and TOR1A. We discuss genetic, clinical and epileptic features comparing our patient with those previously reported in the literature.

Original languageEnglish
Pages (from-to)209-217
Number of pages9
JournalAnnals of Human Genetics
Issue number3
Publication statusPublished - May 1 2015


  • 9q33-q34
  • deletion
  • DNM1
  • early myoclonic encephalopathy
  • EIEE
  • SPTAN1
  • STXBP1

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Early myoclonic encephalopathy in 9q33-q34 deletion encompassing STXBP1 and SPTAN1'. Together they form a unique fingerprint.

Cite this